Loss-of-function mutations in PPP2R1A Correlate with Exceptional Survival in Ovarian Clear Cell Carcinomas Treated with Immune Checkpoint Inhibitors (099) - ScienceDirect
Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis
EPOS™
BioCentury - The latest twist in the overall survival debate
Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma
Cause-specific overall survival of 70 patients with clear cell renal... | Download Scientific Diagram
The impact of increasing dose on overall survival in prostate cancer | Radiation Oncology | Full Text
Prognostic Values of TIGAR Expression and 18F-FDG PET/CT in Clear Cell Renal Cell Carcinoma
Overexpression of NEIL3 associated with altered genome and poor survival in selected types of human cancer - Oanh TN Tran, Serkalem Tadesse, Christopher Chu, Dawit Kidane, 2020
Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell... | Oncotarget
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine | NEJM
JPM | Free Full-Text | Multiomic Analysis of Cereblon Expression and Its Prognostic Value in Kidney Renal Clear Cell Carcinoma, Lung Adenocarcinoma, and Skin Cutaneous Melanoma
![PDF] Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1f748d375710ac0d44f8698fdd5547bca5189c7b/6-Table3-1.png "PDF] Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage | Semantic Scholar")
PDF] Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage | Semantic Scholar
Lentiviral Shrna Constructs Targeting Jade (OriGene) | Bioz | Ratings For Life-Science Research
186 Surgical outcome as prognostic factor in different histologic subtypes of ovarian carcinoma- analysis of 7 phase III trials by AGO Studygroup + ENGOT | International Journal of Gynecologic Cancer
IKCS 2021: Future of Adjuvant Therapy in RCC
BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC) | Anticancer Research
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative | Modern Pathology
Genes | Free Full-Text | Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel towards Prostate Cancer Relapse
Stephen V Liu, MD on X: "#ASCO22 Median OS 14.7m with nivo/ipi vs 9.9 chemo (HR 00.85, p=0.3). OS worse with nivo/ipi in PS2. OS better with nivo/ipi in older pts with
Kaplan-Meier curves for overall survival according to the expression... | Download Scientific Diagram
IKCS 2022: Maturation of Overall Survival (OS) in TIVO-3 with Long-Term Follow-Up
